Abstract:Background: The World Health Organization (WHO) CNS5 classification system highlights the significance of molecular biomarkers in providing meaningful prognostic and therapeutic information for gliomas. However, predicting individual patient survival remains challenging due to the lack of integrated quantitative assessment tools. In this study, we aimed to design a WHO CNS5-related risk signature to predict the overall survival (OS) rate of glioma patients using machine learning algorithms. Methods: We extracted data from patients who underwent an operation for histopathologically confirmed glioma from our hospital database (2011–2022) and split them into a training and hold-out test set in a 7/3 ratio. We used biological markers related to WHO CNS5, clinical data (age, sex, and WHO grade), and prognosis follow-up information to identify prognostic factors and construct a predictive dynamic nomograph to predict the survival rate of glioma patients using 4 kinds machine learning algorithms (RF, SVM, XGB, and GLM). Results: A total of 198 patients with complete WHO5 molecular data and follow-up information were included in the study. The median OS time of all patients was 29.77 [95% confidence interval (CI): 21.19–38.34] months. Age, FGFR2, IDH1, CDK4, CDK6, KIT, and CDKN2A were considered vital indicators related to the prognosis and OS time of glioma. To better predict the prognosis of glioma patients, we constructed a WHO5-related risk signature and nomogram. The AUC values of the ROC curves of the nomogram for predicting the 1, 3, and 5-year OS were 0.849, 0.835, and 0.821 in training set, and, 0.844, 0.943, and 0.959 in validation set. The calibration plot confirmed the reliability of the nomogram, and the c-index was 0.742 in training set and 0.775 in validation set. Additionally, our nomogram showed a superior net benefit across a broader scale of threshold probabilities in decision curve analysis. Therefore, we selected it as the backend for the online survival prediction tool (Glioma Survival Calculator, https://who5pumch.shinyapps.io/DynNomapp/), which can calculate the survival probability for a specific time of the patients. Conclusion: An online prognosis predictor based on WHO5-related biomarkers was constructed. This therapeutically promising tool may increase the precision of forecast therapy outcomes and assess prognosis.

Development of a web-based tool for estimating individualized survival curves in glioblastoma using clinical, mRNA, and tumor microenvironment features with fusion techniques

Multimodal Data Integration Using Deep Learning Predicts Overall Survival of Patients with Glioma

Integrated MRI radiomics, tumor microenvironment, and clinical risk factors for improving survival prediction in patients with glioblastomas

Prognosis and clinical features analysis of EMT-related signature and tumor Immune microenvironment in glioma

Improve Glioblastoma Multiforme Prognosis Prediction by Using Feature Selection and Multiple Kernel Learning

Radiogenomics-Based Risk Prediction of Glioblastoma Multiforme with Clinical Relevance

An online survival predictor in glioma patients using machine learning based on WHO CNS5 data

Identification and validation of a novel robust glioblastoma prognosis model based on bioinformatics

Developing the novel bioinformatics algorithms to systematically investigate the connections among survival time, key genes and proteins for Glioblastoma multiforme

Bioinformatics Analysis and Experimental Validation for Exploring Key Molecular Markers for Glioblastoma

Predictive Analyses of Prognostic-Related Immune Genes and Immune Infiltrates for Glioblastoma

Multiple Survival Outcome Prediction of Glioblastoma Patients Based on Multiparametric MRI

234 Predictive Radiomics in Glioblastoma: A Machine Learning Approach for Personalized Survival Outcomes and a Novel Web Application

Exploring the prognostic value and biological pathways of transcriptomics and radiomics patterns in glioblastoma multiforme

Mining TCGA database for genes of prognostic value in glioblastoma microenvironment

Radiogenomics based survival prediction of small-sample glioblastoma patients by multi-task DFFSP model

Identification and validation of an anoikis-associated gene signature to predict clinical character, stemness, IDH mutation, and immune filtration in glioblastoma

Reproducible and Interpretable Machine Learning-Based Radiomic Analysis for Overall Survival Prediction in Glioblastoma Multiforme

Integrative genomic analysis facilitates precision strategies for glioblastoma treatment

Identification of novel prognostic targets in glioblastoma using bioinformatics analysis

A subregion-based survival prediction framework for GBM via multi-sequence MRI space optimization and clustering-based feature bundling and construction